Introduction:Zhenmai Biotech completed 410 million yuan of B+round financing; Levi can complete a new round of financing of 300 million yuan; Qinglang Intelligent completed round D financing of 200 million US dollars
[Investment and Financing News September 15]Zhenmai Bio is committed to the R&D and manufacturing of upstream technical products in the gene industry, such as gene sequencer and supporting reagents. As a pioneer of the third generation gene sequencing platform in China, the core technology of Zhenmai Biology is single molecule fluorescence sequencing. Recently completed the B+round with a total amount of 410 million yuanfinancing。
Levenen is a battery management system developer, committed to new energyautomobileAnd energy storagemarketBattery system research and development, manufacturing, marketing and technical services. Its main products include vehicle battery system, charger, battery management system, energy storage battery system, etc. Recently, 300 million yuan of financing was completed.
Qinglang Intelligent is a R&D and manufacturer of intelligent service robots. It is committed to applying advanced intelligent service robots and artificial intelligence technologies to create efficient, stable, reliable and practical solutions, and help enterprises in all industries around the world improve service efficiency and achieve intelligent upgrading. Recently completed 2YimeiRMB round D financing.
